Associated Medical Professionals of NY, PLLC

Syracuse, New York 95054

1 studies enrolling now · 10 studies all time

What they study most

Bladder Cancer, Castration-Resistant Prostate Cancer, Low Grade Upper Tract Urothelial Carcinoma, Metastatic Castration Resistant Prostate Cancer, Prostate Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder

Studies at this site

• Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma — Recruiting now
• A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX — Completed
• Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate — Completed
• Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer — Running, not enrolling
• Randomized Controlled Trial of CAN-2409 Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES) — Running, not enrolling
• A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer — Stopped early
• To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer — Stopped early
• Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer — Stopped early
• Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T — Stopped early
• Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer — Completed